Vonoprazan Fumarate is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB) with potential antacid activity. It acts by binding to the gastric hydrogen-potassium ATPase proton pump to inhibit gastric acid secretion.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 881681-01-2
TAK 438
pharmaceutical raw material
Vonoprazan Fumarate
pharmaceutical raw material
Vonoprazan
pharmaceutical raw material
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanol
pharmaceutical intermediate
(+)-catechin monohydrate
pharmaceutical raw material
Netobimin Sodium Salt
pharmaceutical raw material
7,7'-[Butane-1,4-diylbis(oxy)]di(3,4-dihydroquinolin-2(1H)-one)
pharmaceutical raw material
Clodronate disodium tetrahydrate
pharmaceutical raw material
(E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine
ROGSHYHKHPCCJW-WLHGVMLRSA-N
CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=C/C(=O)O)\C(=O)O